The Women’s Brain Foundation began 2026 in the spirit of dialogue and collaboration by being present at the World Economic Forum—our cherished annual tradition. This important gathering once again provided a powerful stage to launch a new year of growth and transformation. At Davos, we advanced critical conversations with scientific, institutional, and policy leaders, reinforcing women’s brain health as a pillar of economic resilience, innovation, and long-term societal sustainability.

We are filled with pride and gratitude for what we have accomplished over nearly ten years of dedicated work. The impact of our efforts continues to exceed our expectations—driven by commitment, vision, and the power of collaboration. What began as a mission to bridge the gender gap in brain and mental health has evolved into a global movement reshaping science, medicine, and policy worldwide.

Our ongoing research on sex- and gender-related factors impacting women’s brain health—including Alzheimer’s, menopause, depression, migraine, caregiving, and other neurological and mental disorders that disproportionately affect women—continues to expand and deepen marked by the launch of our Manifesto for Women’s Brain Health, setting a clear scientific and societal agenda for the decade ahead.

What’s Next? continue reading….

Leave a Reply

Your email address will not be published. Required fields are marked *

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.